Apoptolidins B and C: Isolation, structure determination, and biological activity

Organic Letters

Volumn 7, Issue 14, 2005, Pages 3025-3028

  Wender, Paul A ^a   Sukopp, Martin ^a   Longcore, Kate ^a  

^a STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; APOPTOLIDIN A; APOPTOLIDIN B; APOPTOLIDIN C; MACROLIDE; PYRONE DERIVATIVE;

ACTINOBACTERIA; ARTICLE; CELL CULTURE; CHEMICAL STRUCTURE; CHEMISTRY; DRUG SCREENING; HUMAN; ISOLATION AND PURIFICATION;

ACTINOBACTERIA; ANTINEOPLASTIC AGENTS; DRUG SCREENING ASSAYS, ANTITUMOR; HUMANS; MACROLIDES; MOLECULAR STRUCTURE; PYRONES; TUMOR CELLS, CULTURED;

EID: 22244482218     PISSN: 15237060     EISSN: None     Source Type: Journal    
DOI: 10.1021/ol051074o     Document Type: Article

References (26)

1. Kim, J. W.; Adachi, H.; Shin-ya, K.; Hayakawa, Y.; Seto, H. J. Antibiot. 1997, 50, 628-630.
2. Hayakawa, Y.; Kim, J. W.; Adachi, H.; Shin-ya, K.; Fujita, K.; Seto, H. J. Am. Chem. Soc. 1998, 120, 3524-3525.
3. (a) Salomon, A. R.; Voehringer, D. W.; Herzenberg, L. A.; Khosla, C. Proc. Natl. Acad. Sci. U.S.A. 2000, 97, 14766-14771.
4. (b) Salomon, A. R.; Voehringer, D. W.; Herzenberg, L. A.; Khosla, C. Chem. Biol. 2001, 8, 71-80.
5. Total syntheses: (a) Nicolaou, K. C.; Fylaktakidou, K. C.; Monenschein, H.; Li, Y.; Weyershausen, B.; Mitchell, H. J.; Wei, H.-X.; Guntupalli, P.; Hepworth, D.; Sugita, K. J. Am. Chem. Soc. 2003, 125, 15433-15442.
6. (b) Nicolaou, K. C.; Li, Y.; Sugita, K.; Monenschein, H.; Guntupalli, P.; Mitchell, H. J.; Fylaktakidou, K. C.; Vourloumis, D.; Giannakakou, P.; O'Brate, A. J. Am. Chem. Soc. 2003, 125, 15443-15454 and references therein.
7. (c) Wehlan, H.; Dauber, M.; Mujica Fernaud, M. T.; Schuppan, J.; Mahrwald, R.; Ziemer, B.; Juarez Garciz, M. E.; Koert, U. Angew. Chem., Int. Ed. 2004, 43, 4597-4601.
8. Apoptolidinone: (a) Nicolaou, K. C.; Li, Y.; Weyershausen, B.; Wei, H. Chem. Commun. 2000, 307-308.
9. (b) Schuppan, J.; Wehlan, H.; Keiper, S.; Koert, U. Angew. Chem., Int. Ed. 2001, 40, 2063.
10. Synthesis studies: (a) Schuppan, J.; Ziemer, B.; Koert, U. Tetrahedron Lett. 2000, 41, 621-624.
11. (b) Sulikowski, G. A.; Lee, W.-M.; Jin, B.; Wu, B. Org. Lett. 2000, 2, 1439-1442.
12. (c) Toshima, K.; Arita, T.; Kato, K.; Tanaka, D.; Matsumura, S. Tetrahedron Lett. 2001, 42, 8873-8876.
13. (d) Chng, S.-S.; Xu, J.; Loh, T. P. Tetrahedron Lett. 2003, 44, 4997-5000.
14. (e) Chen, Y.; Evarts Jr. J. B.;, Torres, E.; Fuchs, P. L. Org. Lett. 2002, 4, 3571-3574.
15. (f) Paquette, W. D.; Taylor, R. E. Org. Lett. 2004, 6, 103-106.
16. (g) Abe, K.; Kato, K.; Arai, T.; Rahim, M. A.; Sultana, I.; Matsumura, S.; Toshima K. Tetrahedron Lett. 2004, 45, 8849-8853.
17. (h) Jin, B.; Liu, Q.; Sulikowski, G. A. Tetrahedron 2005, 61, 401-408.
18. (a) Wender, P. A.; Gulledge, A. V.; Jankowski, O. D.; Seto, H. Org. Lett. 2002, 4, 3819-3822.
19. (b) Pennington, J. D.; Williams, H. J.; Salomon, A. R.; Sulikowski, G. A. Org. Lett. 2002, 4, 3823-3825.
20. (a) Salomon, A. R.; Zhang, Y.; Seto, H.; Khosla, C. Org. Lett. 2001, 3, 57-59.
21. (b) Wender, P. A.; Jankowski, O. D.; Tabet, E. A.; Seto, H. Org. Lett. 2003, 5, 487-490.
22. (c) Wender, P. A.; Jankowski, O. D.; Tabet, E. A.; Seto, H. Org. Lett. 2003, 5, 2299-2302.
23. The isomer of apoptolidin B shows slightly lower activity in the H292 cancer cell assay. Structure determination is in progress.
24. Significantly decreased biological activity in H292 cancer cell assay compared to apoptolidin C. Structure determination in progress.
25. Lichtenfels, R.; Biddison, W. E.; Schulz, H.; Vogt, A. B.; Martin, R. J. Immunol. Methods, 1994, 172, 227-239.
26. Jankowski, O. D. Ph.D. Thesis, Stanford University, 2004.